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Abstract
Mouse F9 cells differentiate to primitive endoderm (PrE) when treated with retinoic acid
(RA). Differentiation is accompanied by increased reactive oxygen species (ROS) levels,
and while treating F9 cells with antioxidants attenuates differentiation, H2O2 treatment alone
is sufficient to induce PrE. We identified the NADPH oxidase (NOX) complexes as candidates for the source of this endogenous ROS, and within this gene family, and over the
course of differentiation, Nox1 and Nox 4 show the greatest upregulation induced by RA.
Gata6, encoding a master regulator of extraembryonic endoderm is also up-regulated by
RA and we provide evidence that NOX1 and NOX4 protein levels increase in F9 cells overexpressing Gata6. Pan-NOX and NOX1-specific inhibitors significantly reduced the ability of
RA to induce PrE, and this was recapitulated using a genetic approach to knockdown Nox1
and/or Nox4 transcripts. Interestingly, overexpressing either gene in untreated F9 cells did
not induce differentiation, even though each elevated ROS levels. Thus, the data suggests
that ROS produced during PrE differentiation is dependent in part on increased NOX1 and
NOX4 levels, which is under the control of GATA6. Furthermore, these results suggest that
the combined activity of multiple NOX proteins is necessary for the differentiation of F9 cells
to primitive endoderm.

Introduction
Mouse extraembryonic endoderm formation can be studied in vitro using F9 teratocarcinoma
cells, which are chemically induced to form primitive endoderm (PrE) when treated with retinoic acid (RA) [1] or to parietal endoderm (PE) when treated with RA and cAMP analog [2].
F9 cell differentiation, specifically to PrE is accompanied by the appearance of molecular
markers, and morphological changes, many resulting from the activation of the canonical
Wnt-β-catenin pathway [1]. In this pathway when Wnt is absent a destruction complex serves
to phosphorylate β-catenin marking it for ubiquitination and degradation in the proteasome.
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When present, Wnt binds to a Frizzled receptor causing Dishevelled (DVL) to move towards
the plasma membrane, where it recruits Axin out of the destruction complex making it nonfunctional and allowing β-catenin to accumulate and translocate to the nucleus where it binds
to and activates the T-cell-factors-Lymphoid enhancer factors (TCF-LEF) family of transcription factors. We reported previously that differentiation is also accompanied by a burst of
ROS, which is necessary as F9 cells treated with antioxidants or when treated with a non-specific NADPH oxidase inhibitor failed to form PrE [3]. That H2O2 treatment alone induces PrE
indicates that ROS are sufficient to initiate differentiation [3]. To explore this further, we
recently reported that DVL in undifferentiated F9 cells associates with nucleoredoxin (NRX) a
redox sensitive protein that scavenges ROS, and is known to play a role in PrE differentiation
[4]. This association and regulation of the Wnt-β-catenin pathway occurs in other systems [5–
8], and we propose that this inhibition prevents aberrant canonical Wnt signaling when Wnt
is absent as DVL in this state cannot recruit Axin away from a destruction complex. Thus, in
the presence of ROS NRX dissociates from DVL and the Wnt pathway is primed awaiting the
ligand.
The source of the ROS when F9 cells are treated with RA was investigated and the candidates identified are members of the NADPH oxidase (NOX) family, which are sources of
superoxide anions and H2O2 [9]. In F9 cells Nox1-4 and Duox2 are upregulated following RA
treatment [3]. Duox1 is not RA-responsive and may not be involved in PrE differentiation.
Nox1 and Nox4 are up-regulated to the greatest extent following RA treatment, and given the
previous reports suggesting a link to extraembryonic endoderm formation and stem cell differentiation, we specifically selected these members to interrogate as the candidates involved in
the ROS production involved in RA-induced PrE formation. To address that the activity of
NADPH oxidase 1 and/or 4 is/are responsible for producing the ROS that are necessary and
sufficient to induce F9 cells to differentiate, we first tested and found Nox genes are under
the control of GATA6, the master regulator of endoderm differentiation [10]. Inhibiting all
NOX activity, or specifically inhibiting NOX1 was sufficient to block differentiation, and
knocking down Nox1 or Nox4 expression using an siRNA approach complemented the chemical inhibitor data. Confident from these studies that both NOX proteins were necessary for differentiation, we expected that their overexpression would induce PrE. However, despite the
overexpression of each having increased ROS levels, no significant difference in β-catenindependent TCF activity relative to controls was seen and neither would induce PrE. Together,
these results indicate that RA-induced differentiation of F9 cells requires a coordinate increase
in NOX activity that is due in part to the upregulation of the Nox genes by GATA6.

Materials and methods
Cell culture conditions and transfections
Mouse teratocarcinoma F9 cells (ATCC) were cultured in Dulbecco’s modified Eagles medium
(Lonza) supplemented with 10% fetal bovine serum (Gibco) and 1% penicillin-streptomycin
(Lonza), and incubated at 37˚C and 5% CO2. Cells were treated with 10−7 M retinoic acid (RA
all-trans; Sigma Aldrich) or dimethyl sulfoxide (DMSO; Caledon) as a negative control. Cells
were co-treated with 1 μM VAS2870 (Sigma) and RA 24 hours after seeding and grown for 3
days, or co-treated with 250 nM ML171 (Tocris) and RA and grown for 4 days as described
above. F9 cells were reverse transfected using Lipofectamine 2000 (Thermo Fisher Scientific).
Freshly passaged cells were added to a 35 mm dish already containing a total of 4 μg of DNA
plasmid. Culture media was replenished 6–8 h post-transfection and transfected cells were
selected using antibiotics.
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Plasmids
The following plasmids were used: pcDNA3.1-Gata6; pcDNA-mNox4, a gift from Dr. M.
Jaconi, University of Geneva), pcDNA3.1-mNox1 (Addgene # 58340), pRL-TK, a gift from Dr.
R. DeKoter (Western University), piLenti-siRNA-GFP-Nox1 “CTATTTAACTTCGAACGC
TACAGAAGAAG”, piLenti-siRNA-GFP-Nox1 “TGCTTCCATCTTGAAATCTATCTGGTACA”,
piLenti-siRNA-GFP-Nox4 “ACATTTGGTGTCCACTTTAAAGTAGTAGG”, piLenti-siRNA-GFPNox4 “TCCAGTGGTTTGCAGATTTACTCTGTGTG” (Applied Biological Materials, Richmond
BC).

Immunoblot analysis
Protein lysates were collected in RIPA buffer containing 150 mM sodium chloride, 1.0% Triton X-100, 0.5% deoxycholate, 0.1% SDS and 50 mM Tris pH 8.0. Protein concentrations were
determined using the DC™ Protein Assay (Bio-Rad), and 20–50 μg of protein lysate was mixed
2:1 with 3X SDS loading buffer containing 10% β-mercaptoethanol and separated on 10%
polyacrylamide gels by electrophoresis for 2 h with 100 V at 4˚C. Following electrophoresis,
the proteins were wet-transferred electrophoretically to Immunoblot PVDF membrane (BioRad) for 16 h with 20 V at 4˚C using a Tris-glycine transfer buffer containing 20% methanol.
Membranes were incubated in Tris buffered saline with 0.1% Tween-20 (TBS-T) containing
10% w/v skim milk powder for 1 h shaking at room temperature, then incubated with primary
antibody overnight at 4˚C. Following 3 washes 5 min each in TBS-T, membranes were incubated with secondary antibody for 2 h at room temperature, followed by 3 washes for 10 min
each in TBS-T. SuperSignal West Pico Chemiluminescent Detection Kit (Thermo Fisher Scientific) was used to detect the presence of secondary antibodies conjugated to horseradish peroxidase (HRP). Signals were captured using a Molecular Imager Gel Doc XR system (Bio-Rad)
with Quantity One Software. The primary antibodies used were directed against TROMA1
(1:10; 55 kDa, Developmental Studies Hybridoma Bank), OCT4 (1:1000; 42 kDa, Cell Signaling Technology), DAB2 (1:10000; 96 kDa, BD Transduction Laboratories), NOX1 (1:10000; 65
kDa, Thermo Fisher Scientific), NOX4 (1:10000; 67 kDa, Novus Biologicals) and ß-actin
(1:10000; 47 kDa, Santa Cruz) dissolved in 3% Bovine Serum Albumin w/v in TBS-T. Secondary anti-rat (1:1000), anti-mouse (1:1000) and anti-rabbit (1:1000) antibodies were HRP-conjugated and dissolved in 3% skim milk w/v in TBS-T.

Quantitative reverse transcription polymerase chain reaction
Total RNA from treated and/or transfected cells was isolated and collected using the RNeasy
Mini Kit (Qiagen). RNA was reverse transcribed into first strand cDNA using the HighCapacity cDNA Reverse Transcription Kit (Applied Biosystems) and the manufacturer’s recommendations. The CFX Connect Real-Time PCR Detection System (Bio-Rad) was used for
qRT-PCR analysis. Each reaction contained 500 nM of each primer, SensiFAST SYBR Mix
(FroggaBio), and 1 μL of cDNA. Primers were designed to: L14 F (5’GGGAGAGGTGGCCTCG
GACGC), L14 R (5’GGCTGGCTTTCACTCAAAGGCC), Gata6 F (5’ATGGCGTAGAAATGCTG
AGG), Gata6 R (5’TGAGGTGGTCGCTTGTGTAG), Dab2 F (5’GGAGCATGTAGACCATGATG),
Dab2 R (5’AAAGGATTTCCGAAAGGGCT), Nox1 F (5’AATGCCCAGGATCGAGGT), Nox1 R
(5’GATGGAAGCAAAGGGAGTGA), Nox4 F (5’GATCACAGAAGGTCCCTAGCA), and Nox4 R
(5’GTTGAGGGCATTCACCAAGT). Analysis of gene expression was determined using the
comparative cycle threshold (Δ/ΔCt) method. Gene expression was normalized to the constitutively expressed L14 gene and relative values were normalized by comparing treatments to
DMSO-treated and/or control plasmid transfected control cells to determine fold change.
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TCF reporter assay
Cells were transfected with pGL3-BARL and pRL-TK (transfection control) and then treated
with DMSO (vehicle control), RA, or co-transfected with Nox1 or Nox4 plasmids in equal
amounts of DNA. Protein lysates were collected 3 days post-treatment or post-transfection
using the Dual-Glo Luciferase Assay System and the manufacturer’s recommendations (Promega). Luciferase expression was quantified using the GloMax Multi Detection System (Promega). Values were presented as relative luminescence derived from the quotient of firefly
luminescence (pGL3-BARL) and Renilla luminescence (pRL-TK).

ROS detection
Intracellular ROS was detected using both an Amplex Red Assay and CM-H2DCFDA
(Thermo Fisher Scientific). Briefly, Amplex Red was prepared in DMSO and cells were treated
following manufacturer’s instructions with slight modifications. Following treatment or transfection, cells were detached and resuspended in 100 μM Amplex Red in measurement media
buffer (120 mM KCl, 5 mM KH2PO4, 5 mM EDTA, 10 mM HEPES, 5 mM MgCl2 at pH 7.40)
supplemented with 40 μg/mL Saponin (Sigma) and 0.2 units/mL HRP (Thermo Fisher Scientific). Immediately after incubation, cells were seeded onto an opaque 96-well plate and florescence was measured at Ex/Em of 530/590 nm using the GloMax Multi Detection System
(Promega). Values were normalized to protein concentration. For CM-H2DCFDA staining
cells following treatment with DMSO or RA were incubated in Hank’s Balanced Salt Solution
for 15 min at 37˚C and 5% CO2 with 2 μM CM-H2DCFDA dissolved in DMSO and 10 μg/ml
Hoechst 33342 (Thermo Fisher Scientific). Immediately after incubation, cells were rinsed
twice with PBS and images were captured using a Zeiss Axio Observer A1 inverted microscope
with a QImaging Retiga CCD.

MTT assay
F9 cells were cultured and treated with DMSO, RA, VAS2870 or ML171 for 4 days followed by
incubation in MTT reagent (Sigma) for 2–4 hours at 37˚C and 5% CO2. Media was removed
and DMSO was added to solubilize crystals, and then plates were incubated overnight in the
dark. Absorbance values were measured at 570nm with a reference wavelength at 650nm using
the GloMax1-Multi Detection System (Promega).

Statistical analysis
Data from qRT-PCR, densitometric analysis of immunoblots and Luciferase assays were gathered format least three independent biological replicates. Comparisons of data between control
and experimental groups were performed using a one-way ANOVA with Tukey’s honest significant difference (HSD) post-hoc test or a Student’s t-Test (SPSS Statistics for Windows Version
19.0, IBM Corp. Released 2010, Armonk, NY). Student’s t-Test was used for statistical analysis
of data when comparing control to only one experimental data set and ( ) was used to denote
significant difference. All other data were analyzed using a one-way ANOVA followed by
Tukey’s HSD test and letters were used to indicate significant differences. P-values were considered statistically significant at the 0.05 level. Statistical data are presented as the mean ± SEM.

Results
RA increases NOX1 and NOX4 levels and ROS production
F9 cells treated with RA for 4 days showed a significant increase (P < 0.05) in the expression of
Nox1 (Fig 1A) and Nox4 (Fig 1B), as we have shown previously [3]. Furthermore, NOX1 and
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Fig 1. RA increases NOX1 and NOX4 levels and ROS production. Total RNA and protein was harvested from F9 cells treated
with either DMSO or RA for 4 days. (A) Nox1 and (B) Nox4 expression following DMSO or RA treatment. (C) NOX1 and NOX4
protein levels following DMSO and RA treatment. (D) Protein levels of NADPH oxidase complex accessory subunits NOXA1,
NOXO1, and p22Phox following DMSO and RA treatment. (E) Rac1 expression following DMSO or RA treatment. (F) ROS detection
using CM-H2DCFDA or (G) Amplex Red in F9 cells treated with either DMSO or RA. A total of 3–5 independent experiments were
analyzed and results presented as mean ± SEM. * denotes significance (P < 0.05) tested by a Student’s t-Test.
doi:10.1371/journal.pone.0170812.g001
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NOX4 protein levels also increased after RA treatment (Fig 1C), however, the levels of accessory subunits required for NOX protein function, including NOXA1, NOXO1 and p22Phox
(Fig 1D), or the transcripts encoding Rac1 (Fig 1E), did not appear to change during differentiation. Thus, the subunits to generate functional NOX1 and NOX4 were present in undifferentiated F9 cells. The transcripts encoding the NOX subunits, however, are in low abundance
prior to differentiation to PrE (S1A–S1C Fig). More importantly, elevated ROS production
accompanying differentiation was detected visually by CM-H2DCFDA (Fig 1F), and the significant increase in levels were validated quantitatively using Amplex Red (Fig 1G). When F9
cells were differentiated towards a PE lineage, Nox1 (S2A Fig) and Nox4 (S2B Fig) transcript
levels decreased significantly (P < 0.05) when compared to DMSO- and RA-treated F9 cells. It
should be noted, however, that a significant oxidative state (P < 0.05; S2C Fig) was maintained,
thus suggesting another potential source of ROS when cells differentiate to PE.

Gata6 induction results in increased NOX1 and NOX4 levels
Gata6, a master regulator of endoderm and extraembryonic endoderm formation, is significantly upregulated (P < 0.05) in F9 cells treated with RA (Fig 2A). This evidence, together
with the presence of GATA-binding sites in the Nox1 promoter [11], and that GATA6 is
responsible for increased Nox1 transcription in Caco-2 cells [12] led us to propose that
GATA6 might be responsible for the upregulation of Nox1 and Nox4 in F9 cells preceding
their differentiation. To address this, we overexpressed Gata6 and then analyzed Nox1 and
Nox4 expression and protein levels using qRT-PCR and immunoblot analysis, respectively.
When Gata6 was overexpressed alone (Fig 2B), it induced PrE [10], as evident by the increase
in the differentiation markers DAB2 and TROMA1, and the decrease in the pluripotency
marker OCT4 (Fig 2C). Gata6 overexpression also induced a significant increase (P < 0.05) in
Nox1 (Fig 2D) and Nox4 (Fig 2E) expression. Interestingly, these changes were associated with
an apparent increase in the levels of NOX1 and NOX4 protein (Fig 2F), which were comparable to those seen in RA-treated F9 cells. Together, results indicate that changes in NOX1 and
NOX4 levels accompany F9 cell differentiation to PrE, and would suggest that the increase in
ROS is due in part to these changes. Thus, studies were conducted to determine if the activity
of NOX1 and/or NOX4 is/are required for PrE differentiation.

Pan-NOX inhibition blocks RA-mediated differentiation
Our previous study revealed that Diphenyleneiodonium chloride (DPI), an inhibitor of flavoenzymes that produce ROS attenuates RA-induced PrE differentiation [3]. DPI is used frequently to inhibit ROS production, but since it acts on numerous oxidoreductases, including
the NOX proteins [13] the source of the ROS may not be completely NOX-dependent. To test
the hypothesis that the activity of the NOX proteins is necessary for PrE differentiation, F9
cells were treated with NOX inhibitors. First, the pan-NOX inhibitor, VAS2870 [14, 15] was
used to determine specifically if members of the NOX family were necessary for F9 cells to differentiate to PrE. VAS2870 inhibits NOX1, NOX2 [15] and NOX4 [14], and although it can
inhibit all NOX isoforms it does not serve as an antioxidant because it has no O2- scavenging
effect [14]. VAS2870 treatment showed no significant effect on cell viability relative to the
DMSO control (Fig 3A), but it did cause a significant attenuation (P < 0.05) in the amount of
ROS produced in cells co-treated with RA (Fig 3B). Cells treated with DMSO-, RA-, VAS2870, or co-treated with VAS2870 and RA were examined using qRT-PCR for Dab2 (Fig 3C), and
immunoblot analysis for DAB2, TROMA1 and OCT4 (Fig 3D). Results show that Dab2
expression, relative to the loading control L14, was not significantly different between DMSO
and VAS2870. The expression of Dab2 in F9 cells treated with RA alone was, as expected,
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Fig 2. Gata6 induction results in increased NOX1 and NOX4 levels. Total RNA and protein was collected from F9 cells treated with
DMSO or RA, or transfected with pcDNA3.1-EV (EV) and treated with either DMSO or RA, or transfected with pcDNA3.1-Gata6 (Gata6)
and cultured 4 days. (A) Gata6 expression of F9 cells treated with DMSO or RA. (B) Gata6 expression of F9 cells transfected with EV or
Gata6. (C) Immunoblot analysis for DAB2 (arrow), TROMA1 and OCT4 in F9 cells transfected with EV and treated with DMSO or RA or F9
cells ectopically expressing Gata6. (D) Nox1 and (E) Nox4 expression in F9 cells transfected with EV and treated with DMSO or RA, or F9

PLOS ONE | DOI:10.1371/journal.pone.0170812 February 2, 2017

7 / 20

NOX and mouse extraembryonic endoderm

cells ectopically expressing Gata6. (F) Immunoblot analysis for NOX1 and NOX4 in F9 cells transfected with EV and treated with DMSO or
RA, or F9 cells ectopically expressing Gata6. A total of 3 independent experiments were analyzed and results are presented as
mean ± SEM. * denotes significance (P < 0.05) tested by a Student’s t-Test, whereas letters denote groups of significance (P < 0.05) tested
by a One-Way ANOVA followed by a Tukey’s test.
doi:10.1371/journal.pone.0170812.g002

significantly higher (P < 0.001) from the DMSO treatment, but surprisingly dramatically
reduced in cells treated with RA and VAS2870 (Fig 3C). Immunoblot analysis showed comparable results with elevated DAB2 levels following RA treatment alone (Fig 3D). A similar
increase was seen with the TROMA1 marker, while OCT4 levels decreased with RA treatment.
The OCT4 signal, however, remained elevated in VAS2870 and RA-treated cells, and was comparable to that seen in DMSO-treated cells (Fig 3D). Thus, inhibiting NOX activity attenuates
RA-mediated differentiation, which suggests strongly that NOX complexes are necessary for
F9 cell differentiation.

NOX1-specific inhibition attenuates RA-induced differentiation
F9 cells were treated with 250 nM of ML171, the IC50 of this NOX1-specific inhibitor [16].
ML171 has no ROS scavenging effects [16], and at this concentration it did not have an effect
on F9 cell viability (Fig 3A). Co-treatment with RA, however, showed ROS levels that were significantly lower than those seen in RA-treated F9 cells (Fig 3B). qRT-PCR analysis revealed
that Dab2 expression in DMSO- and ML171-treated F9 cells were not significantly different
from each other, but both were significantly different (P < 0.001) from that in RA-treated F9
cells, and F9 cells co-treated with RA and ML171 (P < 0.05) (Fig 3E). Since Dab2 expression in
cells co-treated with RA and ML171 was significantly lower (P < 0.05) than that in RA-treated
F9 cells (Fig 3E), but not as low as that in cells co-treated with RA and VAS2870 (Fig 3C) this
suggest that inhibiting NOX1 alone was not sufficient in completely attenuating Dab2 expression. Immunoblot analysis for DAB2 and TROMA1 showed no signals in DMSO- or ML171treated F9 cells (Fig 3F). F9 cells co-treated with ML171 and RA, however, showed DAB2 and
TROMA1 signals (Fig 3F), but they appeared to be of less intensity than that seen in the RA
alone lane. OCT4 signals were seen in DMSO-, ML171 and RA- and ML171-treated F9 cells,
but again the intensity appeared reduced in RA-treated F9 cells with or without ML171 (Fig
3F). Since NOX4 was not targeted chemically, as there are no known specific inhibitor(s) that
do not have ROS scavenging effects or additionally target other NOX proteins [16], we can
only conclude that NOX proteins are required for PrE differentiation, and that NOX1 specifically plays a role in this process.

Nox1 and Nox4 knockdown decreases ROS production
To corroborate the chemical inhibitor data, F9 cells were transfected with a siRNA vector to
knockdown Nox1, Nox4 expression or a scrambled siRNA and treated with DMSO or RA as
negative and positive controls, respectively. Since there is a significant increase (P < 0.05) in
Nox1 and 4 expressions after RA treatment (Fig 1A and 1B and S1A–S1C Fig), F9 cells were
treated with RA and the siRNA knockdown efficiency was compared to that seen with the RAtreated scrambled siRNA control. F9 cells containing Nox1 (Fig 4A) and Nox4 (Fig 4C) siRNAs
showed significantly less expression of the respective Nox genes (P < 0.05) when compared to
the RA-treated scrambled control. Both siRNA targeting vectors transfected into cells did not
affect the individual expression of Nox1 or Nox4 (data not shown). The levels of NOX1 (Fig
4B) and NOX4 (Fig 4D) were examined to test if the knockdown effects were seen at the protein level. Results show that levels were significantly lower (P < 0.05) in cells containing the
targeting siRNAs and treated with RA, compared to RA-treated F9 cells transfected with the
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Fig 3. Chemical inhibition of NOX proteins attenuates RA-mediated differentiation of F9 cells. (A) MTT cell viability assay of F9 cells
treated with DMSO, RA, VAS2870 or ML171. (B) F9 cells were treated with DMSO, RA, VAS2870 and RA, or ML171 and RA and assayed
for ROS production using Amplex Red. (C) Dab2 expression of F9 cells treated with DMSO, RA, VAS2870, or VAS2870 and RA. (D)
Immunoblot analysis for DAB2, TROMA1, and OCT4 in F9 cells treated with DMSO, RA, VAS2870, or VAS2870 and RA. (E) Dab2
expression of F9 cells treated with DMSO, RA, ML171, or ML171 and RA. (F) Immunoblot analysis for DAB2, TROMA,1 and OCT4 in F9
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cells treated with DMSO, RA, ML171, or ML171 and RA. β-actin was used as a loading control. A total of 4 independent experiments were
analyzed and results are presented as mean ± SEM. Letters denote groups of significance (P < 0.05) tested by a One-Way ANOVA followed
by a Tukey’s test.
doi:10.1371/journal.pone.0170812.g003

scrambled siRNA. Furthermore, knocking down NOX1 and NOX4 in F9 cells treated with RA
showed a significant reduction (P < 0.05) in ROS levels compared to those seen in cells transfected with the scrambled siRNA and treated with RA (Fig 4E).

Nox1 and Nox4 knockdown attenuates RA-induced differentiation
qRT-PCR and immunoblotting were used to determine if the knockdowns would affect Dab2
expression (Fig 5A) or levels of DAB2, TROMA1, and/or OCT4 protein (Fig 5B–5D). Analysis
showed that compared to RA treatment, a significant reduction (P < 0.05) in Dab2 expression
(Fig 5A) was seen when either Nox1 or Nox4 expression was knocked down. Also, there was
no significant difference between the individual knockdowns compared to that due to the
knockdown of both genes together. As expected, DAB2 and TROMA1 levels were low or not
detected in cells transfected with the scrambled siRNA and treated with DMSO, however they
did increase significantly in cells treated with RA (Fig 5B and 5C). Also, it is interesting to note
that DAB2 levels in cells transfected with the targeted siRNAs and treated with RA were not
significantly different between those transfected with the scr siRNA and treated with either
DMSO or RA. However, TROMA1 levels were significantly lower in cells transfected with targeted siRNAs and treated with RA than RA treated cells transfected with scr siRNA (P < 0.05)
(Fig 5C). OCT4 levels were high in the DMSO-treated scr siRNA control cells, but these were
significantly reduced (P < 0.05) in F9 cells transfected with either the scr siRNA and treated
with RA or those transfected with the siRNA targeting vectors and treated with RA (Fig 5B
and 5D). Together with the inhibitor data, these results would indicate that NOX1 and NOX4
play a role in PrE differentiation.

Overexpressing Nox1 and Nox4 increases ROS production
Since the inhibitor and genetic knockdown studies attenuated the formation of PrE, and our
earlier study showing F9 cells treated with H2O2 develop into PrE [3], it seemed logical to propose that Nox overexpression should induce F9 cells. To test if Nox1 or Nox4 overexpression
induced differentiation, F9 cells were transfected with pcDNA3.1-EV and treated with either
DMSO or RA or transfected with pcDNA3.1-Nox1 or -Nox4. The relative degree of overexpression was determined by qRT-PCR, and results showed an approximate 700 and 1800-fold
increase for Nox1 (Fig 6A) and Nox4 (Fig 6B), respectively. Similarly, NOX1 and NOX4 protein levels were higher in F9 cells transfected with the respective Nox construct (Fig 6C and
6D). Having established that transfection resulted in elevated NOX1 and NOX4 levels, we
examined if this would affect ROS levels. For the positive control, F9 cells transfected with
pcDNA3.1-EV and treated with RA showed a significant increase (P < 0.05) in ROS levels
over those seen in transfected cells treated with DMSO (Fig 6E). Note that the levels seen following RA treatment were comparable to those in cells transfected with either Nox1 or Nox4.

Nox overexpression activates canonical Wnt signaling, but does not
promote differentiation
The overexpression results and those from earlier studies [3, 4] suggested that the increased
levels in ROS due to ectopic Nox1 or Nox4 expression would activate canonical Wnt-β-catenin
signaling. To test this F9 cells were co-transfected with Nox1 or Nox4, and the firefly luciferase
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Fig 4. Nox1 and Nox4 knockdown reduces ROS production. Total RNA was collected from F9 cells transfected with
scrambled (scr) si-RNA, si-Nox1 and/or si-Nox4 siRNA and cultured 4 days with RA treatment. (A) Expression of Nox1 and
(B) NOX1 protein levels following transfection with scr or si-Nox1 and RA treatment. (C) Expression of Nox4 and (D) NOX4
protein levels following transfection with scr or si-Nox1 and RA treatment. (E) ROS production detected using Amplex Red
of F9 cells transfected with scr, si-Nox1, or si-Nox4 and treated with RA. A total of 3 independent experiments were
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analyzed and results are presented as mean ± SEM. * denotes significance (P < 0.05) tested by a Student’s t-Test, whereas
letters denote groups of significance (P < 0.05) tested by a One-Way ANOVA followed by a Tukey’s test.
doi:10.1371/journal.pone.0170812.g004

pGL3-BARL reporter that is used as readout for active Wnt-β-catenin signaling [17]. All cells
were transfected with the Renilla luciferase construct, TK-RL to normalize for luciferase
expression. RA-treated F9 cells transfected with pcDNA3.1-EV showed a significant increase
(P < 0.05) in TCF activity compared to the DMSO control (Fig 7A). F9 cells overexpressing
Nox1 or Nox4 also showed increased TCF activity, however, this increase was less than that
seen in RA-treated F9 cells, and was not significant from either RA or DMSO treatments (Fig
7A). Nevertheless, F9 cells overexpressing Nox1 or Nox4 were analyzed for PrE differentiation,
and as expected Dab2 expression relative to the L14 loading control was significantly higher
(P < 0.001) in RA-treated F9 cells than that in DMSO treated cells (Fig 7B and 7C). Dab2
expression resulting from either the overexpression of Nox1 (Fig 7B) or Nox4 (Fig 7C) was not
significantly different from that in DMSO-treated F9 cells, suggesting that differentiation had
not occurred. Similarly, DAB2 protein was only present in RA-treated cells, and this evidence
of differentiation was seen in the corresponding increase in TROMA1 and concomitant
decrease in OCT4 levels (Fig 7D). TROMA1 signals were not seen in DMSO-treated, Nox1-,
Nox4-, or Nox1 and Nox4-overexpressing cells, and the appearance of OCT4 in the same samples was indicative that PrE had not differentiated as a result of Nox1 and/or Nox4 overexpression (Fig 7D). Thus, even though overexpressing Nox1 or Nox4 in F9 cells increased ROS
levels, there was no significant activation of Wnt-β-catenin signaling or hallmark molecular
indicators of PrE to suggest that the overexpression of Nox1, Nox4 or both was sufficient to
induce differentiation.

Discussion
ROS, which are by-products of metabolic processes produced through the incomplete reduction of oxygen, create oxidative stress on cells, and damage nucleic acids, proteins and lipids.
Although this damage is linked to age-related and other human disease pathogenesis, recent
studies now show cells benefitting from ROS as a second messenger to modulate biological
processes such as differentiation, apoptosis and proliferation [18, 19]. F9 cells are induced to
form primitive endoderm when treated with RA, an in vitro process that mimics a very early
event in mouse embryogenesis. Differentiation is accompanied by numerous changes in gene
expression and morphology and requiring several signaling pathways. One of these pathways
involves canonical Wnt-β-catenin signaling [1], where Wnt6 is induced by GATA6 [10] a master regulator of extraembryonic and embryonic endoderm. Regulation of this Wnt pathway
occurs in a redox-regulated manner [3] involving NRX and DVL, the latter serving as a lynchpin in the three major Wnt signaling pathways [4]. We have shown previously that cytosolic
ROS plays a role in F9 cell differentiation to form primitive endoderm [3]. ROS impact positively on the canonical Wnt-β-catenin signaling pathway, and the Nox genes that are upregulated in response to RA were identified as candidates responsible for this cytosolic ROS [3].
Increases in mitochondrial ROS have been also observed in F9 cells differentiated to primitive
and parietal endoderm, a consequence of what appears to be a metabolic transition from aerobic glycolysis towards oxidative phosphorylation (manuscript in preparation). This increase in
mitochondrial ROS might explain the maintained oxidative state of F9 cells at PE, despite the
reduction in Nox1 and Nox4 expression (S2A and S2B Fig).
The expression profiles of the six mouse Nox genes led us to interrogate Nox1 and Nox4,
which were the most up-regulated in response to RA in F9 cells [3]. In addition to RA (Fig
1A–1D), both genes are up-regulated, and the level of the corresponding proteins increase in
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Fig 5. Nox1 and Nox4 knockdown attenuates RA-induced differentiation. RNA was collected from F9 cells transfected with scrambled (scr) si-RNA,
si-Nox1 and/or si-Nox4 siRNA and cultured 4 days with RA treatment. (A) Dab2 expression of F9 cells transfected with scr, si-Nox1, or si-Nox4 and treated
with RA. (B) Immunoblot analysis for DAB2, TROMA1, and OCT4 in F9 cells transfected with scr, si-Nox1, or si-Nox4 and treated with RA. (C)
Densitometric analysis for DAB2, TROMA1, and (D) OCT4 in F9 cells transfected with scr, si-Nox1, or si-Nox4 and treated with RA. β-actin was used as a
loading control. A total of 3 independent experiments were analyzed and results are presented as mean ± SEM. Letters and symbols denote groups of
significance (P < 0.05) tested by a One-Way ANOVA followed by a Tukey’s test.
doi:10.1371/journal.pone.0170812.g005
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Fig 6. Overexpressing Nox1 and Nox4 increases ROS production. Total RNA was collected from F9 cells transfected with an
empty vector (EV) control, pcDNA3.1-Nox1 or pcDNA3.1-Nox4 and cultured 4 days. (A) Nox1 and (B) Nox4 expression following
transfection of pcDNA3.1-Nox1 or pcDNA3.1-Nox4, respectively, and relative to EV transfected cells. (C) NOX1 and (D) NOX4
protein levels following transfection of pcDNA3.1-Nox1 or pcDNA3.1-Nox4, respectively, relative to EV transfected cells. (E) ROS
production using Amplex Red in F9 cells transfected with EV and treated with DMSO or RA, or transfected with pcDNA3.1-Nox1 or

PLOS ONE | DOI:10.1371/journal.pone.0170812 February 2, 2017

14 / 20

NOX and mouse extraembryonic endoderm

pcDNA3.1-Nox4. A total of 3 independent experiments were analyzed and results are presented as mean ± SEM. * denotes
significance (P < 0.05) tested by a Student’s t-Test, whereas letters denote groups of significance (P < 0.05) tested by a One-Way
ANOVA followed by a Tukey’s test.
doi:10.1371/journal.pone.0170812.g006

response to GATA6 (Fig 2D–2F). Previous studies provide evidence for a link between
GATA6 and Nox genes, specifically Nox1, which is activated directly by GATA6 [11, 12].
NOX1 impacting on Wnt signaling occurs in colonic and intestinal epithelial cells [8, 20], and
it is known to post-transcriptionally increase the levels of Keratin 18 [21], a cytokeratin
encoded by transcripts that increase during RA-induced F9 cell differentiation [22]. Furthermore, NOX1 and NOX4 activate the p38 MAPK pathway in mouse and human cells [23, 24],
which is also required to inhibit GSK-3β thereby maintaining Wnt in the on-state during PrE
differentiation [25]. Evidence for NOX4 interacting with Wnt signaling or regulated by GATA
transcription factors is not as compelling as NOX1. However, it is interesting to note a study
showing the opposite scenario exists in cardiomyocytes, where NOX4 increases Gata4 expression [26]. Other reports have linked NOX4 to cell proliferation, cytoskeletal reorganization,
migration and differentiation [27–30], which incidentally are processes that F9 cells participate
in during differentiation [31].
Having identified that NOX1 and NOX4 were under the indirect or direct control of
GATA6, we next used chemical inhibitors to test whether or not the activity of both NOX proteins were required for PrE differentiation. As noted above, a previous study in our lab using
the non-specific flavoenzyme inhibitor DPI, demonstrated the necessity for ROS in the differentiation of F9 cells [3]. Since DPI acts on other non-NOX flavoenzymes [13], we refined
the approach and used a pan-NOX and NOX1-specific inhibitor to test their effects on differentiation (Fig 3). Both inhibitors affected differentiation at the gene and protein levels, but
VAS2870, the pan-NOX inhibitor was more potent than ML171, the selective inhibitor of
NOX1 activity (Fig 3). Although there could be many reasons to explain this, the fact that all
the NOX proteins were being inhibited by VAS2870 would suggest that multiple NOX proteins contribute to the ROS required for differentiation. This argument would be tested later
as these pharmacological inhibitor studies proved informative, but required a genetic approach
to corroborate the data. Mouse knockout models exist for all 6 Nox genes [14, 32, 33], but disrupting any one of them individually or in combination does not appear to have obvious
effects in embryos. Therefore, an alternative strategy was to use siRNAs, which have had some
success in knocking down the expression of specific Nox genes [14]. This approach was used
to knockdown Nox1 and/or Nox4 gene expression, and it resulted in reduced expression and
protein levels of NOX1 and NOX4 (Fig 4A–4D). Knockdown led to the attenuation of differentiation, as evident by the decrease in the markers of PrE, and the maintenance of pluripotency as noted by the persistence of the OCT4 signal (Fig 5A–5D). Together with the inhibitor
results, this data adds support that NOX activity, specifically from NOX1 and NOX4, is necessary for F9 cells to form PrE. While encouraged by these results, the contribution to the differentiation process by the two other Nox genes and Duox2 that are upregulated by RA in F9 cells
needs to be considered and is currently under investigation.
Although NOX1 and NOX4 are members of the NOX subfamily that require p22phox, the
former generates primarily superoxide, while the major product of the latter is H2O2 [34].
Nox4 is widely expressed in human, while Nox1 is much more restricted [32]. Nevertheless,
there is overlap in places where functional redundancy might explain why the in vivo knockout models do not show obvious phenotypes. This does not appear to be the case for the F9
in vitro cell model as there was a common effect seen when knocking down either Nox1 or
Nox4. Thus, it is possible that attenuating the activity of one NOX isoform in vitro reduces

PLOS ONE | DOI:10.1371/journal.pone.0170812 February 2, 2017

15 / 20

NOX and mouse extraembryonic endoderm

Fig 7. Nox overexpression activates canonical Wnt signaling, but does not promote differentiation. (A) Dual-luciferase assay of
TCF activity in F9 cells transfected with EV and treated with DMSO or RA, or transfected with pcDNA3.1-Nox1 or pcDNA3.1-Nox4. (B)
Dab2 expression in F9 cells transfected with EV and treated with DMSO or RA, or transfected with pcDNA3.1-Nox1. (C) Dab2 expression
in F9 cells transfected with EV and treated with DMSO or RA, or transfected with pcDNA3.1-Nox4. (D) Immunoblot analysis for DAB2,
TROMA1, and OCT4 in F9 cells transfected with EV and treated with DMSO or RA, or transfected with pcDNA3.1-Nox1, pcDNA3.1-Nox4
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or both vectors. β-actin was used as a loading control. A total of 3 independent experiments were analyzed and results are presented as
mean ± SEM. Letters denote groups of significance (P < 0.05) tested by a One-Way ANOVA followed by a Tukey’s test.
doi:10.1371/journal.pone.0170812.g007

the total amount of ROS required for differentiation, and this cannot be compensated by the
other members. The overexpression of either Nox1 and/or Nox4 (Fig 6A–6D) in F9 cells nevertheless resulted in increased ROS levels (Fig 6E), and what appeared to be an increase in
canonical Wnt signaling (Fig 7A). However, these increases were not sufficient to induce differentiation as seen following the application of exogenous H2O2 [3]. Although there is
much debate centered on the recently reported Nox1, Nox2 and Nox4 triple knockout mouse
model [33], our information would indicate that ROS produced individually by at least two
of the NOX isoforms is necessary in the F9 cell model of primitive extraembryonic endoderm
formation. Building from previous studies our model now adds to the signaling hierarchy
and crosstalk within these networks where RA induces Gata6 expression, which in turn regulates several genes including Wnt6 [10], Nox1 and Nox4 (this study). The subsequent increase
in ROS permits NRX to dissociate from DVL, thereby priming the Wnt pathway [4] prior to
the appearance of the WNT6 ligand that is sufficient to promote PrE differentiation [1].
WNT6 signaling is attenuated in a negative feedback loop involving Dickkopf-1 [35], and
this is required for PrE cells to complete their differentiation to PE [36]. Given the report
showing canonical Wnt signaling activates RAC1 and this in turn increases RAC1-dependent NOX1 activity that produces the ROS needed to oxidize NRX and dissociate it from
DVL in order to keep the pathway in the on-state [8], it is tempting to speculate that a similar
mechanism occurs in F9 cells in response to RA. However, since NOX4 is not RAC1-dependent [9], and is required for PrE differentiation (this study), canonical Wnt signaling must
be stimulating NOX4 activity in another manner. Given that the production of ROS is
increased as a direct result of increased NOX4 expression [37], the possibility exists that
increased NOX4 activity is the result of an upregulation in the Nox4 gene by active Wnt signaling. Towards that end, experiments are underway to test if the Nox genes are WNT target
genes or simply downstream in the pathway. Whatever the case, that aberrant Wnt signaling
is prevalent in cancer biology [38, 39] underpins the importance of better understanding the
crosstalk imparted by NOX proteins and ROS on the Wnt-β-catenin signaling pathway in
both development and cancer research.

Supporting information
S1 Fig. Nox1 and Nox4 are upregulated during RA-treatment. Total RNA was collected
from F9 cells treated with DMSO or RA for 4 days. (A) Ct values for Nox1 and Nox4 under
DMSO or RA treatment. (B and C) Graphical illustration of Ct values of Nox1 and Nox4
under DMSO or RA treatment over 40 cycles. L14 served as a control.
(EPS)
S2 Fig. F9 cells show reduction in Nox1 and Nox4 expression yet maintain high oxidative
state at PE. Total RNA was collected from F9 cells induced to differentiate into PrE and PE.
Expression of Nox1 (A) and Nox4 (B) following DMSO, RA, and RA with db-cAMP treatment. (C) Oxidative state of F9 cells following treatment with DMSO, RA, RA with db-cAMP.
A total of 4 independent experiments were analyzed and results are presented as mean ± SEM.
Letters denote groups of significance (P < 0.05) tested by a One-Way ANOVA followed by a
Tukey’s test.
(EPS)
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